NESS-040C5

 Share 

NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma. It has reasonable selectivity for the CB2 receptor subtype, having a CB2 affinity of 0.4nM, and 25x selectivity over the related CB1 receptor.

See also

• AB-FUBINACA
• NESS-0327
• SR-144,528